Cheng Jie, Wang Hua, Guggino William B
Department of Physiology, The Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205, USA.
J Biol Chem. 2005 Feb 4;280(5):3731-9. doi: 10.1074/jbc.M410026200. Epub 2004 Nov 15.
The cystic fibrosis transmembrane conductance regulator (CFTR)-interacting protein, CFTR-associated ligand (CAL) down-regulates total and cell surface CFTR by targeting CFTR for degradation in the lysosome. Here, we report that a Rho family small GTPase TC10 interacts with CAL. This interaction specifically up-regulates CFTR protein expression. Co-expression of the constitutively active form, TC10Q75L, increases total and cell surface CFTR in a dose-dependent fashion. Moreover, co-expression of the dominant-negative mutant TC10T31N causes a dose-dependent reduction in mature CFTR. The effect of TC10 is independent of the level of CFTR expression, because a similar effect was observed in a stable cell line that expresses one-tenth of CFTR. Co-expression of TC10Q75L did not have a similar effect on the expression of plasma membrane proteins such as Frizzled-3 and Pr-cadherin or cytosolic proteins such as tubulin and green fluorescent protein. TC10Q75L also did not have a similar effect on the vesicular stomatitis virus glycoprotein. Co-expression of constitutively active and dominant-negative forms of Cdc42 or RhoA did not affect CFTR expression in a manner similar to TC10, indicating that the effect of TC10 is unique within the Rho family. Metabolic pulse-chase experiments show that TC10 did not affect CFTR maturation, suggesting that it exerts its effects on the mature CFTR. Importantly, TC10Q75L reverses CAL-mediated CFTR degradation, suggesting that TC10Q75L inhibits CAL-mediated degradation of CFTR. TC10Q75L does not operate by reducing CAL protein expression or its ability to form dimers or interact with CFTR. Interestingly, the expression of TC10Q75L causes a dramatic redistribution of CAL from the juxtanuclear region to the plasma membrane where the two molecules overlap. These data suggest that TC10 regulates both total and plasma membrane CFTR expression by interacting with CAL. The GTP-bound form of TC10 directs the trafficking of CFTR from the juxtanuclear region to the secretory pathway toward the plasma membrane, away from CAL-mediated degradation of CFTR in the lysosome.
囊性纤维化跨膜传导调节因子(CFTR)相互作用蛋白,CFTR相关配体(CAL)通过将CFTR靶向溶酶体进行降解,从而下调CFTR的总量及细胞表面表达。在此,我们报道Rho家族小GTP酶TC10与CAL相互作用。这种相互作用特异性地上调CFTR蛋白表达。组成型活性形式TC10Q75L的共表达以剂量依赖性方式增加CFTR的总量及细胞表面表达。此外,显性负性突变体TC10T31N的共表达导致成熟CFTR呈剂量依赖性减少。TC10的作用独立于CFTR的表达水平,因为在表达量为正常十分之一的稳定细胞系中也观察到了类似的效应。TC10Q75L的共表达对诸如卷曲蛋白3和原钙黏蛋白等质膜蛋白或诸如微管蛋白和绿色荧光蛋白等胞质蛋白的表达没有类似影响。TC10Q75L对水泡性口炎病毒糖蛋白也没有类似影响。组成型活性和显性负性形式的Cdc42或RhoA的共表达没有以类似于TC10的方式影响CFTR表达,这表明TC10的作用在Rho家族中是独特的。代谢脉冲追踪实验表明TC10不影响CFTR成熟,提示它对成熟的CFTR发挥作用。重要的是,TC10Q75L逆转CAL介导的CFTR降解,提示TC10Q75L抑制CAL介导的CFTR降解。TC10Q75L并非通过降低CAL蛋白表达或其形成二聚体或与CFTR相互作用的能力来发挥作用。有趣的是,TC10Q75L的表达导致CAL从近核区域显著重新分布到质膜,在质膜处这两种分子重叠。这些数据提示TC10通过与CAL相互作用来调节CFTR的总量及质膜表达。TC10的GTP结合形式引导CFTR从近核区域转运至分泌途径并朝向质膜,从而避免CFTR在溶酶体中被CAL介导降解。